The repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection - PubMed (original) (raw)
The repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection
L McMahan et al. J Virol. 1990 Jul.
Abstract
The phenotypic properties of ICP27 temperature-sensitive and deletion mutants and the results of transient expression assays have demonstrated that ICP27 has a modulatory effect on viral gene expression induced by ICPs 0 and 4. In order to identify the regions of the ICP27 molecule that are responsible for its enhancing and repressing activities, 10 nonsense and 3 in-frame deletion mutations were introduced into the coding sequence of the cloned ICP27 gene. These mutant genes were tested in transient expression assays for their ability to complement an ICP27 null mutant and to enhance and repress expression from a spectrum of herpes simplex virus type 1 promoters in reporter CAT genes when expression was induced by ICP0 or ICP4. The results of assays with cloned mutant genes demonstrate that the ICP27 polypeptide contains two regions, located between amino acid residues 327 and 407 and residues 465 and 511, that contribute to its repressing activity. The amino acid region located between the two repressing regions (residues 407 to 465) is able to interfere with ICP27 repressing activity. None of the mutant genes exhibited efficient enhancing activity for any of the herpes simplex type 1 promoters tested, demonstrating that amino acids comprising the carboxy-terminal half of the ICP27 molecule, including the terminal phenylalanine residue, are required for wild-type enhancement as well as for efficient complementation of an ICP27 null mutant. Phenotypic characterization of an in-frame deletion mutant, vd3, and a previously isolated null mutant, 5dl 1.2 (A. M. McCarthy, L. and P. A. Schaffer, J. Virol. 63:18-27, 1989), demonstrated that ICP27 is required to induce the expression of all classes of viral genes very early in infection and confirmed the requirement for ICP27 later in infection (i) to repress early gene expression, (ii) to induce wild-type levels of delayed-early or gamma 1 gene expression, and (iii) to induce true late or gamma 2 gene expression. The vd3 mutant, which specifies an ICP27 peptide lacking the repressing region between residues 327 and 407, is able to (i) repress early gene expression, consistent with the repressing ability of the d3 mutation in transient expression assays, (ii) induce the synthesis of significant but reduced levels of delayed-early (gamma 1) proteins and no gamma 2 proteins (thus vd3 exhibits a late protein phenotype intermediate between that of the wild-type virus and 5dl 1.2), and (iii) confer altered electrophoretic mobility on ICP4, demonstrating a role for ICP27 in the posttranslational modification of this essential regulatory protein.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule.
Hardwicke MA, Vaughan PJ, Sekulovich RE, O'Conner R, Sandri-Goldin RM. Hardwicke MA, et al. J Virol. 1989 Nov;63(11):4590-602. doi: 10.1128/JVI.63.11.4590-4602.1989. J Virol. 1989. PMID: 2552143 Free PMC article. - Mutations in the activation region of herpes simplex virus regulatory protein ICP27 can be trans dominant.
Smith IL, Sekulovich RE, Hardwicke MA, Sandri-Goldin RM. Smith IL, et al. J Virol. 1991 Jul;65(7):3656-66. doi: 10.1128/JVI.65.7.3656-3666.1991. J Virol. 1991. PMID: 1645788 Free PMC article. - Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient.
McCarthy AM, McMahan L, Schaffer PA. McCarthy AM, et al. J Virol. 1989 Jan;63(1):18-27. doi: 10.1128/JVI.63.1.18-27.1989. J Virol. 1989. PMID: 2535723 Free PMC article. - The many roles of the regulatory protein ICP27 during herpes simplex virus infection.
Sandri-Goldin RM. Sandri-Goldin RM. Front Biosci. 2008 May 1;13:5241-56. doi: 10.2741/3078. Front Biosci. 2008. PMID: 18508584 Review. - A Revision of Herpes Simplex Virus Type 1 Transcription: First, Repress; Then, Express.
Dunn LEM, Birkenheuer CH, Baines JD. Dunn LEM, et al. Microorganisms. 2024 Jan 26;12(2):262. doi: 10.3390/microorganisms12020262. Microorganisms. 2024. PMID: 38399666 Free PMC article. Review.
Cited by
- Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells.
Aubert M, Rice SA, Blaho JA. Aubert M, et al. J Virol. 2001 Jan;75(2):1013-30. doi: 10.1128/JVI.75.2.1013-1030.2001. J Virol. 2001. PMID: 11134315 Free PMC article. - Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step.
Bryant HE, Wadd SE, Lamond AI, Silverstein SJ, Clements JB. Bryant HE, et al. J Virol. 2001 May;75(9):4376-85. doi: 10.1128/JVI.75.9.4376-4385.2001. J Virol. 2001. PMID: 11287586 Free PMC article. - Stress-induced cellular transcription factors expressed in trigeminal ganglionic neurons stimulate the herpes simplex virus 1 ICP0 promoter.
Sinani D, Cordes E, Workman A, Thunuguntia P, Jones C. Sinani D, et al. J Virol. 2013 Dec;87(23):13042-7. doi: 10.1128/JVI.02476-13. Epub 2013 Sep 11. J Virol. 2013. PMID: 24027338 Free PMC article. - Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release.
Ralph WM Jr, Cabatingan MS, Schaffer PA. Ralph WM Jr, et al. J Virol. 1994 Nov;68(11):6871-82. doi: 10.1128/JVI.68.11.6871-6882.1994. J Virol. 1994. PMID: 7933067 Free PMC article. - Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis.
Jordan R, Schaffer PA. Jordan R, et al. J Virol. 1997 Sep;71(9):6850-62. doi: 10.1128/JVI.71.9.6850-6862.1997. J Virol. 1997. PMID: 9261410 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1985 Aug;82(16):5265-9 - PubMed
- J Virol. 1985 Sep;55(3):796-805 - PubMed
- J Virol. 1986 May;58(2):583-91 - PubMed
- Mol Cell Biol. 1985 Aug;5(8):1997-2008 - PubMed
- Cell. 1986 Sep 26;46(7):1043-51 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous